NCT06552468Completed
A Study on the Effectiveness of the Application of an Artificial Intelligence Algorithm for Calibrating PPG With ECG to Improve the Accuracy of Atrial Fibrillation Burden Estimation
Source: ClinicalTrials.gov · Last updated 31 Dec 2024
Brief summary (registry, in English)
Use the ECG watch to collect W-PPG and W-ECG data. Through artificial intelligence algorithms, compare the W-PPG data collected by the ECG watch and the W-PPG data calibrated by the W-ECG data of the ECG watch with the P-ECG data manually annotated after being collected by the ECG recorder. Then evaluate the effectiveness of the calibrated algorithm in improving the accuracy of estimating atrial fibrillation burden.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 1054 (actual)
- First submitted
- 4 Aug 2024
- Start date
- 14 Jan 2024
- Primary completion date
- 27 Jun 2024
- Lead sponsor
- Beijing Anzhen Hospital
- Diseases
- Atrial fibrillation
- NCT number
- NCT06552468
What you commit to
- Study type: Observational
- Participants enrolled: 1054
- From 14 Jan 2024 to the primary completion date, 27 Jun 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Those with chronic insomnia who have not received drug treatment.
Other illness
- Severe skin diseases such as severe skin allergies or skin ulcers.
- Patients with severe cardiovascular and cerebrovascular diseases who may need emergency treatment at any time.
- Those with a history of Parkinson's disease, schizophrenia, or epilepsy.
Other
- Patients who meet any of the following criteria cannot be included in this study:
- Unable to complete the wearing due to problems such as limited mobility.
- Black people and those with overly dark skin.
Who the study is looking for
- Patients must meet all of the following criteria to be included in the study:
- Aged 18 and above;
- There was a clear electrocardiogram record of atrial fibrillation in the past, and atrial fibrillation ablation surgery will be performed during this hospitalization；
- Patients who agree to wear both the "ECG watch" and the "ECG recorder" simultaneously；
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Beijing Anzhen Hospital Coordinator of this site? Confirm its status | Beijing | China | Unknown status |
Related publications
- A Dual-Modal Wearable PPG Smartwatch with AI-Enhanced Correction for High-Accuracy and Continuous AF Burden Assessment.Adv Sci (Weinh) · 2026 · PMID 42446176
This page is information, not medical advice. Discuss any trial with your doctor.